中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页 机构 成果 学者
  
  1. CAS IR Grid
机构
  • 合肥物质科学研究院 [25]
采集方式
内容类型
发表日期
学科主题
筛选

浏览/检索结果: 共25条，第1-10条 帮助

限定条件                
条数/页： 排序方式：
Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study 期刊论文  OAI收割
BLOOD ADVANCES, 2023, 卷号: 7
作者:  Bachy, Emmanuel;  Savage, Kerry J.;  Huang, Huiqiang;  Kwong, Yok-Lam;  Gritti, Giuseppe
  |  收藏  |  浏览/下载：17/0  |  提交时间：2023/11/10
Magnetic properties and critical behavior of quasi-2D layered Cr4Te5 thin film 期刊论文  OAI收割
FRONTIERS OF PHYSICS, 2023, 卷号: 18
作者:  Liu, Hao;  Fan, Jiyu;  Zheng, Huan;  Wang, Jing;  Ma, Chunlan
  |  收藏  |  浏览/下载：50/0  |  提交时间：2022/12/23
Tislelizumab, a PD-1 inhibitor for relapsed/refractory mature T/NK-cell neoplasms: Results from a phase 2 study. 期刊论文  OAI收割
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Bachy, Emmanuel;  Savage, Kerry J.;  Huang, Huiqiang;  Kwong, Yok-Lam;  Gritti, Giuseppe
  |  收藏  |  浏览/下载：11/0  |  提交时间：2022/12/23
Disease progression patterns and molecular resistance mechanisms to crizotinib of lung adenocarcinoma harboring ROS1 rearrangements 期刊论文  OAI收割
NPJ PRECISION ONCOLOGY, 2022, 卷号: 6
作者:  Zhang, Yongchang;  Huang, Zhe;  Zeng, Liang;  Zhang, Xiangyu;  Li, Yizhi
  |  收藏  |  浏览/下载：42/0  |  提交时间：2022/05/05
Zanubrutinib monotherapy for relapsed or refractory non-germinal center diffuse large B-cell lymphoma 期刊论文  OAI收割
BLOOD ADVANCES, 2022, 卷号: 6
作者:  Yang, Haiyan;  Xiang, Bing;  Song, Yuqin;  Zhang, Huilai;  Zhao, Weili
  |  收藏  |  浏览/下载：24/0  |  提交时间：2022/12/23
Tislelizumab for Relapsed/Refractory Classical Hodgkin Lymphoma: 3-Year Follow-up and Correlative Biomarker Analysis 期刊论文  OAI收割
CLINICAL CANCER RESEARCH, 2022, 卷号: 28
作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng
  |  收藏  |  浏览/下载：51/0  |  提交时间：2022/05/05
Tislelizumab Plus GemOx in Patients with Relapsed/Refractory Classic Hodgkin Lymphoma: A Single-Arm, Multi-Center Phase II Trial 期刊论文  OAI收割
BLOOD, 2021, 卷号: 138
作者:  Ding, Kaiyang;  Liu, Hailing;  Yang, Haiyan;  Cao, Lei;  Zhao, Xiaoli
  |  收藏  |  浏览/下载：19/0  |  提交时间：2022/12/23
The Interim Efficacy of Epigenetic Priming Regimen with Azacytidine and Chidamide in Patients with Relapsed or Refractory Peripheral T Cell Lymphoma 期刊论文  OAI收割
BLOOD, 2021, 卷号: 138
作者:  Ding, Kaiyang;  Shi, Xiao;  Yang, Haiyan;  Cao, Lei;  Zhao, Xiaoli
  |  收藏  |  浏览/下载：13/0  |  提交时间：2022/12/23
Efficacy and Safety of Recombinant Human-Mouse Chimeric Anti-CD20 Monoclonal Antibody (SCT400) Combined with CHOP in Patients with Treatment-Naive Diffuse Large B-Cell Lymphoma: A Multicenter, Randomized, Single-Blind, Parallel Active-Controlled, Phase III Study 期刊论文  OAI收割
BLOOD, 2021, 卷号: 138
作者:  Shi, Yuankai;  Zhang, Qing Yuan;  Hong, Xiaonan;  Wang, Zhen;  Gao, Yuhuan
  |  收藏  |  浏览/下载：30/0  |  提交时间：2022/12/23
If small molecules immunotherapy comes, can the prime be far behind? 期刊论文  OAI收割
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 卷号: 218
作者:  Zhang, Jingyu;  Zhang, Yu;  Qu, Bingxue;  Yang, Haiyan;  Hu, Shengquan
  |  收藏  |  浏览/下载：50/0  |  提交时间：2021/06/15